Periodic Reporting for period 2 - SHIGETECVAX (Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea)

Summary
Shigella and enterotoxigenic Escherichia coli (ETEC) are among the leading causes of diarrhoea worldwide especially in low- and middle-income countries (LMIC) where these pathogens account for about 200 million episodes of diarrhoea per year. Prolonged and/or repeated...
More information & hyperlinks